3623 results for «2520»
3623 results
How to understand the ISCHEMIA trial?
27 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to get a better understanding of what the ISCHEMIA trial is about and what it is not about, and to make up your own opimind on the strength of the ISCHEMIA conclusions based on its methodology and results.
This session was...
DES and bioadaptator technologies in contemporary practice
21 May 2025 – From EuroPCR 2025
Delve into contemporary practice with this session on drug-eluting stents (DES) and bioadaptator technologies. Gain insights from international studies on complex PCI outcomes, comparative data from randomized trials, and real-world experiences focusing on high bleeding risk patients and elderly cohorts treated with ultrathin strut and new-generation...
Multi-modality assessment of coronary disease
21 May 2025 – From EuroPCR 2025
This session offers comprehensive multi-modality assessment of coronary disease, integrating advanced imaging and functional testing. Topics include diagnostic yield of OCT and cardiac MRI for MINOCA, transitioning coronary plaque vulnerability assessment from invasive to non-invasive methods, relationships between QFR and IVUS post-PCI in complex lesions, combined...
Will the Evolut Low Risk trial change my practice?
22 May 2019 – From EuroPCR 2019
Consult this session to learn all about the Evolut Low Risk TAVI trial, whose goal was to assess the safety and efficacy of transcatheter aortic valve replacement with the self-expanding CoreValve, compared with surgical aortic valve replacement in low-risk patients. Discover how its results apply to your practice!
Will the PARTNER 3 Low Risk trial change my practice?
21 May 2019 – From EuroPCR 2019
Consult this session to learn more about the relevance of the PARTNER 3 Low Risk TAVI trial, how the results apply to specific patients and how they may impact your clinical practice.
TAVI 1: durability, mismatch and challenging anatomy
18 May 2023 – From EuroPCR 2023
Explore TAVI longevity: Five-year Portico valve outcomes, bioprosthetic dysfunction post-surgery or self-expanding TAVI, prosthesis-patient mismatch impact, and innovative valve-in-valve TAVI insights, and more.
Innovative strategies for coronary interventions
22 May 2025 – From EuroPCR 2025
Explore innovative strategies in coronary interventions, including the EPIC26 sirolimus-eluting stent study, use of percutaneous ventricular assist devices in high-risk patients, the SCORE multicenter study on SeQuent SCB, DCB versus DES for ostial left circumflex lesions, and site-specific antithrombotic therapy outcomes from the DESyne BDS Plus...
Hotline TAVI 3: Challenging anatomical and clinical scenarios
22 May 2025 – From EuroPCR 2025
This hotline session presents challenging anatomical and clinical scenarios in TAVI, including outcomes in bicuspid aortic valve patients, chronic aortic regurgigation, comparisons of surgical versus percutaneous approaches, and real-world data on valve performance and resource utilization.
Inludes:
- Five-year outcomes from the Evolut low risk TAVR bicuspid study
- Surgical versus...
Has the 2023 ESC-EACTS guideline review on left main changed my practice?
15 May 2024 – From EuroPCR 2024
Watch this session if you wish to learn why the 2019 guidelines were revised, how to apply the updated recommendations in clinical settings through case examples, and the criteria for selecting patients with left main stenosis for PCI versus CABG.
The session includes detailed presentations on...
EuroPCR 2019 Hot Line and Trial Update
21 May 2019 – From EuroPCR 2019
Consult this session to learn all about the results of the latest trials : discover more about the COAPT trial, examining the relationship between residual mitral regurgitation and clinical outcomes, the GLOBAL Leaders substudy, examining ticagrelor monotherapy in complex PCI, and the BIO-RESORT, determining the clinical outcomes following treatment...
Trials and registries - Managing bleeding risk in search of optimal drug-device synergy
23 May 2019 – From EuroPCR 2019
Consult this session to discover the results of the latest trials and registries for the management of bleeding risk in search of optimal drug-device synergy: ROBOT-ACS, GLOBAL LEADERS, SAFE-A, and more!
Rapid-Fire clinical cases: Session 3
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of clinical cases presented during PCR LV 2022: tunnel stent technique as an alternative treatment for left main protection in valve-in-valve TAVI, coronary embolisation due to valve-in-valve aortic prothesis thrombosis, aortic prosthetic valve dysfunction due to endocarditis, and more!
Rapid-fire abstracts: Session 6
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: hydrodynamic performance of ACURATE neo2 for valve-in-valve across different surgical bioprostheses, impact of leaflets splitting on coronary access after redo TAVI in failed supra-annular platforms, same-day discharge after TF and alternate access...
Rapid-fire abstracts: Session 7
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: contemporary outcome of high surgical risk mitral regurgitation, quantitative flow ratio vs. FFR for coronary functional evaluation in patients undergoing TAVI, videodensitometric quantification of paravalvular leak after implantation of the new Myval-Octacor,...
Transcatheter mitral valve interventions: clinical outcomes 1
28 Nov 2022 – From PCR London Valves 2022
Consult this session on transcatheter mitral valve interventions to discover a selection of abstracts submitted during PCR London Valves 2022: one-year outcomes for transcatheter mitral repair from the MiCLASP study, the Edwards PASCAL transcatheter mitral valve repair system study, one-year outcomes of Tendyne TMVR treating symptomatic MR,...
Rapid-fire clinical cases: Session 4
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: the buddy wire technique used with three different transcatheter heart valve systems, acute right coronary artery occlusion caused by calcium embolisation during TAVI, off-label temporary left ventricle haemodynamic support via Impella CP...
TAVI challenges: session 2
28 Nov 2022 – From PCR London Valves 2022
Watch this PCR LV 2022 session to learn how to treat TAVI with severe peripheral calcifications, a complex TAVI with extreme tortuous and horizontal aorta, or even TAVI in aortic regurgitation patient after failed attempt with commercial device.
Rapid-fire abstracts: Session 8
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: ultrasound-guided vs. conventional MANTA vascular closure device deployment after TAVR, novel aortic regurgitation quantification after Portico TAVI, mid-term outcome of TAVI using Myval transcatheter heart valve in severe bicuspid aortic stenosis, and...
TAVI challenges: session 3
28 Nov 2022 – From PCR London Valves 2022
View a radial access balloon aortic valvuloplasty adapting to the challenge of small arteries, a semi-inflated buddy balloon for percutaneous TAVR in severe calcified bicuspid aortic valve, and long-term outcome of TAVR in mucopolysaccharidosis type I-HS in this PCR LV 2022 session, among others!
Rapid-fire abstracts: Session 9
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: impact of different aortic valve calcification pattern on the haemodynamic performance of self-expanding intra-annular transcatheter heart valve, device failure in bicuspid aortic stenosis following TAVR, the learning curve and clinical outcomes in...
